Latest Us Market Transition News

Elixinol Wellness has finalized the divestment of its US operations to Ananda Health, securing upfront and deferred payments totaling approximately A$465,000. This move refocuses the company on its Australian health and wellness portfolio while reducing exposure to US regulatory risks.

Amaero has taken a key step toward listing in the US by confidentially submitting its draft registration statement to the SEC, though pricing and timing remain undecided.

Amaero Ltd has amended its scheme implementation deed, revising the consideration offered to option holders as it progresses with its re-domiciliation from Australia to the US. Key milestones for the transition are scheduled through mid-2026.